Glaukos said on Wednesday patients treated with its late-stage eye disease therapy maintained improvements ​in vision and corneal shape three years ‌after a single treatment for keratoconus, a disease that can progressively distort vision.

Log in or sign up to comment.

No comments yet.

← Back to stories